Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eliquis (Apixaban) Regulatory Postmarketing Surveillance in Clinical Practice for Stroke Prevention in Nonvalvular Atrial Fibrillation

NCT01885598 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT01885598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01885598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eliquis (Apixaban) Regulatory Postmarketing Surveillance in Clinical Practice for Stroke Prevention in Nonvalvular Atrial Fibrillation
Lead sponsor
Bristol-Myers Squibb
Phase
Observational
Overall status
Completed
Start date
July 10, 2013
Completion date
September 29, 2017
Enrollment
3,335 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonvalvular atrial fibrillation